Is this a new category of drugs to treat Hep C? I believe so. This one is called “an oral uridine nucleotide analog polymerase inhibitor of HCV.” Could I have some comment from a doctor or researcher please?

http://enterprisepost.com/biomed/bio/psi-7977-receives-fast-track-designation-from-the-fda-for-the-treatment-of-chronic-hepatitis-c-infection.html

Watch this video on a new type of drug being tested on chimps in Texas. Sounds promising!

http://lloydwright.org/messages/content/hepatitis-c-breakthrough

http://sify.com/news/diabetes-obesity-drugs-may-help-treat-hepatitis-c-news-international-kgiouldihbd.html

Telaprevir is testing well in clinical trials – 75% cure rate for 24 week treatment.  It is not approved by the FDA yet, but application for approval will be made probably later this year. So far, it needs to be used with Interferon, but researchers hope that will change in the near future.

http://www.nytimes.com/2010/05/26/health/research/26drug.html

Tarmogen Vaccine, GI-5005, increased virologicl response in phase II trial.

http://www.docguide.com/news/content.nsf/news/852576140048867C8525770D0067832B

http://www.newstimes.com/health/article/Hepatitis-C-tied-to-higher-kidney-cancer-risk-445379.php

Too many abnormalities halt clinical trial:

http://www.bizjournals.com/sanjose/stories/2010/04/19/daily22.html

Here’s another drug to keep an eye on. Early phase I studies show promise:

“The Bristol-Myers compound works differently than a new class of drugs called protease inhibitors being developed by Merck’s Schering-Plough division and Vertex Pharmaceuticals Inc .

SUPPRESSING VIRAL LOAD

Meanwell said BMS-790052 helps inhibit the hepatitis C virus from replicating.

Infected patients who got a single 100 milligram dose of the compound saw their viral load — a measurement of the virus in their blood — drop more than 99.9 percent.”

Check it out at:

http://www.reuters.com/article/idUSTRE63K5QB20100421

Here’s an interesting blog to follow. This first entry starts with a history of  HCV discovery and treatment. Keep an eye on this one.

http://caps.fool.com/Blogs/ViewPost.aspx?bpid=349095&t=01007366137242330765

Locteron is a controlled release interferon alpha that is administered every 2 weeks and has a better side effect  profile than currently available Pegasys (R)  and PEG-Intron .

http://www.marketwire.com/press-release/Biolex-Announces-Presentation-EASL-Interim-Results-From-EMPOWER-Phase-2b-Study-Locteron-1148840.htm